SmartZyme To Present At Ladenburg Thalmann 2015 Healthcare Conference

NESS ZIONA, Israel--(BUSINESS WIRE)--SmartZyme, a biopharmaceutical company utilizing a proprietary technological platform called Provolution™ for protein design and engineering of both new and better therapeutics, today announced that management will make a corporate presentation at the Ladenburg Thalmann 2015 Healthcare Conference on September 29th at 1:30 p.m. Eastern Time. The conference is being held at the Sofitel Hotel in New York City. Doug Kohrs, chairman, Shilo Ben Zeev, chief executive officer and David Baram, Ph.D, president and chief technology will discuss the Company’s progress with its fast-acting coagulation factor for blood clotting and its progress with licensing its innovative enzyme and device for diabetic blood glucose monitoring.

Help employers find you! Check out all the jobs and post your resume.